Search

everythinglearnresearchcommunity

for

Search:↓

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Stem cells can move to brain injury sites and be tracked, showing promise for treating brain diseases.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Mexican patients had a lower incidence of skin reactions to drugs and no significant link between these reactions and the TNF2 gene variant.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

miR-3606-3p reduces skin fibrosis by blocking key signaling pathways.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

The tumor suppressor BRCA2 helps in cell division by bringing key proteins to the area where cells split.

MEX3A is crucial for maintaining intestinal stem cells in mice.

Cannabidivarin (CBDV) may help brain cell growth and survival through the TRPV1 receptor.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

JAGGED1 could help regenerate tissues for bone loss and heart damage if delivered correctly.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Cinainu is effective and safe for treating children's alopecia areata.

Tryptanthrin effectively suppresses non-melanoma skin cancer and is safe for normal skin.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Surgical excision is the best treatment for SCC, but intralesional cidofovir might be a good alternative.

Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.

SH-340 may improve skin barrier and help treat atopic dermatitis.

Cuscuta reflexa extract may help treat benign prostatic hyperplasia by reducing inflammation and oxidative stress.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Centipeda minima and brevilin A protect skin cells from damage and aging.

A new CDH3 gene mutation was found in a Spanish patient with sparse hair and eye issues.

Mice with extra PKCδ resist chemical-induced skin cancer but not UV-induced.